Cargando…

Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a progressive lungs disease that affects women at reproductive years. Sirolimus inhibits mammalian target of rapamycin (mTOR) and its administration in past studies was hopeful in treatment of patients with LAM. The aim of this study was to evaluate siro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aghaeimeybodi, Fatemeh, Najafizadeh, Katayoun, Razavi-Ratki, Seyd-Kazem, Namiranian, Nasim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386328/ https://www.ncbi.nlm.nih.gov/pubmed/30858935 http://dx.doi.org/10.22088/cjim.10.1.7

Ejemplares similares

Factors Associated with Breast Cancer Screening Decision Stage among Women in Tehran, Iran
por: Nojomi, Marzieh, et al.
Publicado: (2014)

Depression and general anxiety in the prisoner of war's children: a cross sectional study
por: Razavi, Seyed Hossein, et al.
Publicado: (2012)

Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: A cross-sectional study
por: Dehghan, Elahe, et al.
Publicado: (2022)

Could heart rate recovery and exercise capacity predict abnormal 99mTc-MIBI myocardial perfusion scan findings?
por: Naghedi, Aryan, et al.
Publicado: (2021)

Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus
por: Ko, Yuki, et al.
Publicado: (2020)

Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
por: Zhan, Yongzhong, et al.
Publicado: (2018)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis
por: Steagall, Wendy K., et al.
Publicado: (2023)

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
por: Hu, Siqi, et al.
Publicado: (2019)

Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
por: Neurohr, Claus, et al.
Publicado: (2011)

Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus
por: Sakaue, Takahiko, et al.
Publicado: (2018)

Sirolimus in lymphangioleiomyomatosis: A case in point for research in ‘orphan’ diseases
por: Koul, Parvaiz A, et al.
Publicado: (2019)

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
por: Gopalakrishnan, Vissagan, et al.
Publicado: (2018)

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis
por: Namba, Masashi, et al.
Publicado: (2017)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
por: Freitas, Carolina Salim Gonçalves, et al.
Publicado: (2015)

Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
por: Zhou, Li, et al.
Publicado: (2018)

Successful Sirolimus Treatment of Lymphangioleiomyomatosis in a Hepatitis B Virus Carrier
por: Sonobe, Shoko, et al.
Publicado: (2018)

Sirolimus Suppresses Phosphorylation of Cofilin and Reduces Interstitial Septal Thickness in Sporadic Lymphangioleiomyomatosis
por: Huang, Yen-Lin, et al.
Publicado: (2021)

Comparative Diagnostic Performance of Ultrasonography and 99mTc-Sestamibi Scintigraphy for Parathyroid Adenoma in Primary Hyperparathyroidism; Systematic Review and Meta-Analysis
por: Moghadam, Reza Nafisi, et al.
Publicado: (2017)

Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
por: Sakurai, Teiko, et al.
Publicado: (2021)

Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
por: Verma, Ajay Kumar, et al.
Publicado: (2018)

Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience
por: Revilla-López, Eva, et al.
Publicado: (2021)

Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Repeated Remote Ischemic Conditioning Effect on Ankle-brachial Index in Diabetic Patients - A Randomized Control Trial
por: Shahvazian, Najmeh, et al.
Publicado: (2017)

Lung Transplantation for Lymphangioleiomyomatosis in Japan
por: Ando, Katsutoshi, et al.
Publicado: (2016)

The lung microbiome in end-stage Lymphangioleiomyomatosis
por: Ng, Julie, et al.
Publicado: (2021)

Bronchiolitis Obliterans Syndrome and Death in Iranian Lung Transplant Recipients: A Bayesian Competing Risks Analysis
por: Hosseini-Baharanchi, Fatemeh Sadat, et al.
Publicado: (2016)

Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014)

Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response ,
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2013)

The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis
por: Xu, Wenshuai, et al.
Publicado: (2021)

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Can Antidepressant Drug Impact on Blood Pressure Level in Patients with Psychiatric Disorder and Hypertension? A Randomized Trial
por: Razavi Ratki, Seyed Kazem, et al.
Publicado: (2016)

Total pleural coverage followed by lung transplantation in patient with lymphangioleiomyomatosis
por: Kim, Do Hyung, et al.
Publicado: (2019)

Coexistent sarcoidosis and lymphangioleiomyomatosis in a patient with cystic lung disease
por: Cullivan, Sarah, et al.
Publicado: (2018)

Refractory chylous effusions in lymphangioleiomyomatosis patient post lung transplant
por: Jacob, Samuel, et al.
Publicado: (2020)

Comparison of the Effects of Plasmapheresis, Hemoperfusion, and Convalescent Plasma Therapy on Inflammatory Factors in COVID-19 Patients
por: Akhlaghi, Sedighe Sadadt, et al.
Publicado: (2022)

Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response
por: Miller, Suzanne, et al.
Publicado: (2020)

Treatment of lymphangioleiomyomatosis and Camões
por: Rufino, Rogério
Publicado: (2015)

Methylprednisolone in the treatment of lymphangioleiomyomatosis
por: Dale, Ventour, et al.
Publicado: (2022)

Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
por: Gámez-Baeza, Pablo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d2shhb06joia2qiagfcqs03mtj